Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Boxer Capital Management, LLC (CIK 2018299) reported $761.7M across 52 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: TNGX ($227.5M, 29.87%), KOD ($51.9M, 6.81%), RVMD ($48.6M, 6.38%), KYMR ($27.4M, 3.60%), CELC ($25.7M, 3.37%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | TNGX | TANGO THERAPEUTICS INC | $227.5M | 29.87% | 10.9M | Hold |
| 2 | KOD | KODIAK SCIENCES INC | $51.9M | 6.81% | 1.4M | Added |
| 3 | RVMD | REVOLUTION MEDICINES INC | $48.6M | 6.38% | 500,000 | Added |
| 4 | KYMR | KYMERA THERAPEUTICS INC | $27.4M | 3.60% | 329,100 | Hold |
| 5 | CELC | CELCUITY INC | $25.7M | 3.37% | 225,000 | Hold |
| 6 | SRZN | SURROZEN INC | $22.3M | 2.93% | 766,318 | Added |
| 7 | ABVX | ABIVAX SA | $22.3M | 2.92% | 200,000 | Added |
| 8 | TERN | TERNS PHARMACEUTICALS INC | $19.8M | 2.60% | 375,000 | Hold |
| 9 | PCVX | VAXCYTE INC | $18.9M | 2.48% | 325,000 | New |
| 10 | CAPR | CAPRICOR THERAPEUTICS INC | $17.9M | 2.35% | 590,000 | Added |
| 11 | PTGX | PROTAGONIST THERAPEUTICS INC | $17.9M | 2.35% | 170,000 | Hold |
| 12 | VIR | VIR BIOTECHNOLOGY INC | $16.7M | 2.20% | 1.9M | Added |
| 13 | CRVS | CORVUS PHARMACEUTICALS INC | $16.1M | 2.11% | 1.1M | New |
| 14 | PRAX | PRAXIS PRECISION MEDICINES I | $15.0M | 1.97% | 46,457 | Hold |
| 15 | PTCT | PTC THERAPEUTICS INC | $13.6M | 1.79% | 200,000 | Hold |
| 16 | PGEN | PRECIGEN INC | $13.5M | 1.78% | 3.5M | Added |
| 17 | DEFINIUM THERAPEUTICS INC | $11.3M | 1.49% | 598,500 | New | |
| 18 | AMLX | AMYLYX PHARMACEUTICALS INC | $11.1M | 1.46% | 800,000 | Hold |
| 19 | QURE | UNIQURE NV | $10.8M | 1.42% | 662,000 | Added |
| 20 | IRD | OPUS GENETICS INC | $10.2M | 1.34% | 2.2M | New |
| 21 | CORT | CORCEPT THERAPEUTICS INC | $10.1M | 1.32% | 250,000 | New |
| 22 | REPL | REPLIMUNE GROUP INC | $9.0M | 1.18% | 1.2M | Added |
| 23 | URGN | UROGEN PHARMA LTD | $9.0M | 1.18% | 500,000 | Hold |
| 24 | COGT | COGENT BIOSCIENCES INC | $8.7M | 1.14% | 225,000 | Hold |
| 25 | PALI | PALISADE BIO INC | $8.4M | 1.10% | 4.8M | Hold |
Source: SEC Form 13F filings · as of 2026-03-31